CURASAN AG
DGAP-News: curasan AG
/ Key word(s): 9 Month figures
curasan stabilizes portfolio business in the third quarter and intensifies partner search - Net group revenues increased by 5.4 percent to 4.6 million Euro - EBITDA at -2.2 million Euro represent a significant improvement following comprehensive cost reductions - New CEO puts clear focus on strategic partnerships Kleinostheim, 21 November 2019 - curasan AG, Germany, (ISIN DE000A2YPGM4) a leading specialist for medical products in the field of orthobiologics, succeeded in significantly increasing its net group revenues in the first three quarters of 2019 compared to the same period of the previous year thus stabilizing its portfolio business. Net group revenues in the first nine months of 4.6 million Euro were 5.4 percent above the previous year (9M 2018: 4.4 million Euro). Already prior to the change in the board of directors mid September the company decided to significantly cut expenditures. By this, curasan succeeded to reduce important cost blocks sustainably. Correspondingly, the loss decreased to 0.6 million Euro (Q3 2018: -1.6 million Euro) and the EBITDA of the first nine months improved to -2.2 million Euro (9M 2018: -2.8 million Euro) although comprising the cost for the Extraordinary General Meeting as well as the issuance of the convertible bonds of around 0.2 million Euro in the first half year of 2019. The key financial figures on the development of earnings in the first nine months of 2019 are as follows:
Turnover by regions developed as follows in the first nine months:
For the further financing of business operations, the company had issued a convertible bond in May. In July 2019 the company also carried out a capital increase with subscription rights for the shareholders, through which the company received approximately EUR 3.1 million. Other key financial ratios developed as follows:
"Despite extensive efforts in the past years curasan did not manage to reach the break-even point through growth out of its own remarkable strengths", Torben Sorensen draws up as summary. "In order to get there we aim at comprehensive strategic partnerships with well established providers in the field of medical devices. Furthermore, we are evaluating options to acquire promising complementary products - if appropriate also within or by support of further capital measures - or to sell own products which could be marketed in a better way by third parties. Therefore, it is my number one priority to put these measures on the way in order to be able to operate sustainably as soon as possible." Based on the new strategy, already in July the company had announced the acquisition of JEDER GmbH located in Klosterneuburg/Vienna, Austria, a provider in the field of dental technology, which will be consolidated with effect of December 31, 2019 for the first time. By the JEDER technology platform curasan plans to generate additional turnover in the coming year via cross selling. "We can draw important conclusions from the development in the last years. In particular, that our products are without any doubt of premium quality, but also, that this fact alone is not going to secure curasan's success", explains Torben Sorensen. "By product bundling with other high quality products from the dental technology field our quality can be established in the market much faster." Against the backdrop of the currently reconsolidated operative development of the company the Management Board expects to close the 2019 financial year in line with the full-year forecast. You find more information on Curasan AG and its product range under www.curasan.com. Contact curasan AG:
21.11.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
| Language: | English |
| Company: | curasan AG |
| Lindigstraße 4 | |
| 63801 Kleinostheim | |
| Germany | |
| Phone: | 06027/40 900 0 |
| Fax: | 06027/40 900 29 |
| E-mail: | info@curasan.de |
| Internet: | www.curasan.de |
| ISIN: | DE000A2YPGM4 |
| WKN: | A2YPGM |
| Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 918411 |
| End of News | DGAP News Service |
918411 21.11.2019
